• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Global Life Science Ventures

edit

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Milestones

edit

• 
  Global Life Science Ventures invested in Action Pharma. (7/16/10)
  Posted 7/16/10 at 5:59pm via onbiovc.com
• 
  Global Life Science Ventures invested in PIERIS Proteolab. (11/1/06)
  Posted 4/25/10 at 9:10pm
• 
  Global Life Science Ventures invested in Agendia. (8/28/07)
  Posted 3/11/10 at 4:43am via agendia.com
• 
  Global Life Science Ventures invested in Coapt Systems. (12/29/09)
  Posted 12/31/09 at 4:18am via venturebeat.com
• 
  Global Life Science Ventures invested in Agendia. (9/23/09)
  Posted 9/24/09 at 1:53am via fiercebiotech.com
• 
  Global Life Science Ventures invested in Coapt Systems. (3/29/07)
  Posted 9/16/09 at 3:51am via venturebeat.com

Investments

Videos

Sources

1. Action Pharma, A/S: Series C $6.3M (onbiovc.com) [edit]
2. Coapt Systems takes $3.7M for facial rejuvenation (deals.venturebeat.com) [edit]
3. Agendia closes $23M Series E financing (fiercebiotech.com) [edit]
4. Agendia BV raises $34M and Receives Second FDA Clearance (agendia.com) [edit]
5. Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more (deals.venturebeat.com) [edit]
6. Cap Funding Report [edit]